Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuta Tanaka

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
International Journal of Cancer|June 12, 2023
Association between immune checkpoint inhibitor-induced myocarditis and concomitant use of thiazide diureticsSatoru Mitsuboshi, Hirofumi Hamano, Takahiro Niimura, et al.
Bioorganic & Medicinal Chemistry|April 20, 2018
Discovery of novel serine palmitoyltransferase inhibitors as cancer therapeutic agentsTakuto Kojima, Yasutomi Asano, Osamu Kurasawa, et al.
Elife|May 20, 2017
Chemical structure-guided design of dynapyrazoles, cell-permeable dynein inhibitors with a unique mode of actionJonathan B Steinman, Cristina C Santarossa, Rand M Miller, et al.
ACS Pharmacology & Translational Science|April 8, 2020
Novel Pure αVβ3 Integrin Antagonists That Do Not Induce Receptor Extension, Prime the Receptor, or Enhance Angiogenesis at Low ConcentrationsJihong Li, Yoshiyuki Fukase, Yi Shang, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
International Journal of Cancer|June 12, 2023
Association between immune checkpoint inhibitor-induced myocarditis and concomitant use of thiazide diureticsSatoru Mitsuboshi, Hirofumi Hamano, Takahiro Niimura, et al.
Bioorganic & Medicinal Chemistry|April 20, 2018
Discovery of novel serine palmitoyltransferase inhibitors as cancer therapeutic agentsTakuto Kojima, Yasutomi Asano, Osamu Kurasawa, et al.
Elife|May 20, 2017
Chemical structure-guided design of dynapyrazoles, cell-permeable dynein inhibitors with a unique mode of actionJonathan B Steinman, Cristina C Santarossa, Rand M Miller, et al.
ACS Pharmacology & Translational Science|April 8, 2020
Novel Pure αVβ3 Integrin Antagonists That Do Not Induce Receptor Extension, Prime the Receptor, or Enhance Angiogenesis at Low ConcentrationsJihong Li, Yoshiyuki Fukase, Yi Shang, et al.
Pageof 10